NASDAQ: XLABExascale Labs Holdings Inc Stock
$2.35+0.99 (+72.79%)
Updated Oct 16, 2026
XLAB Price
$2.35
Fair Value Price
N/A
Market Cap
$151.19M
52 Week Low
$0.78
52 Week High
$11.17
P/E
-12.43x
P/B
-6.01x
P/S
45.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.82M
Earnings
-$12.16M
Gross Margin
16.3%
Operating Margin
-82.05%
Profit Margin
-82.1%
Debt to Equity
-1.27
Operating Cash Flow
-$3M
Beta
0.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XLAB Overview
Exascale provides dedicated, scalable GPU compute and AI-ready data center solutions to a diversified customer base spanning enterprise AI developers, academic institutions, and AI-native platforms.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XLAB's potential to beat the market
- XLAB doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Software Infrastructure
Industry Rating
C
XLAB
RankedUnranked of 129
RankedUnranked of 129
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $38.07 | A | |
| $6.90 | A | |
| $37.20 | A |
Be the first to know about important XLAB news, forecast changes, insider trades & much more!
XLAB News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XLAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XLAB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XLAB is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
XLAB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more XLAB due diligence checks available for Premium users.
Valuation
XLAB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-12.43x
Industry
197.99x
Market
42.68x
XLAB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-6.01x
Industry
8.44x
XLAB's financial health
Profit margin
Revenue
$14.8M
Net Income
-$18.7M
Profit Margin
-126%
XLAB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
XLAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.7M
Liabilities
$31.9M
Debt to equity
-1.27
XLAB's short-term liabilities ($31.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XLAB's short-term assets ($6.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XLAB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XLAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.1M
Investing
$0.0
Financing
-$281.0M
XLAB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
XLAB vs Software Infrastructure Stocks
Exascale Labs Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.